A Phase II trial of Ofatumumab in patients with lymphoma of the of the mucosa associated lymphoid tissue (MALT-Lymphoma) (O-MA 1)
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Ofatumumab (Primary)
- Indications Marginal-zone-B-cell-lymphoma
- Focus Therapeutic Use
- Acronyms O-MA1
- 01 Feb 2018 Results published in the Hematological Oncology
- 29 Sep 2016 Status changed from recruiting to completed.
- 29 Sep 2015 Interim results of 13 patients were presented at the European Cancer Congress 2015.